Orion inks $200m deal to sell diagnostics unit

Orion said today that it plans to sell its Orion Diagnostica division to an investment fund managed by Axcel Management for $200 million.

The Finland-based company said its diagnostic unit operates independently from its pharmaceutical business and that the two groups have “material business synergies.”